A PHASE 1 OPEN-LABEL CROSSOVER STUDY TO EVALUATE BIOEQUIVALENCE OF ORAL SUSPENSION AND TABLET FORMULATIONS OF PERAMPANEL IN HEALTHY SUBJECTS

被引：0
|
作者：
Laurenza, A. [1 ]
Hall, N. [1 ]
Majid, O. [2 ]
Rege, B. [1 ]
机构：
[1] Eisai Inc, Woodcliff Lake, NJ USA
[2] Eisai Ltd, Hatfield, Herts, England
来源：
EPILEPSIA | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P561
引用
收藏
页码：170 / 171
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects
    Sun, Feifei
    Liu, Yanping
    Li, Ting
    Lin, Pingping
    Jiang, Xin
    Li, Xin
    Wang, Chenjing
    Gao, Xiaomeng
    Ma, Yaping
    Fu, Yao
    Cao, Yu
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [22] Bioequivalence of Two Tablet Formulations of Clopidogrel in Healthy Argentinian Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
    Di Girolamo, Guillermo
    Czerniuk, Paola
    Bertuola, Roberto
    Keller, Guillermo A.
    CLINICAL THERAPEUTICS, 2010, 32 (01) : 161 - 170
  • [23] Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions
    Genis-Najera, Luis
    Sanudo-Maury, Maria Elena
    NEUROLOGY AND THERAPY, 2024, 13 (01) : 141 - 152
  • [24] Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions
    Luis Genis-Najera
    Maria Elena Sañudo-Maury
    Neurology and Therapy, 2024, 13 : 141 - 152
  • [25] A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
    Mario Tanguay
    Thomas Fröhlich
    Mathieu Drouin
    Gerald Beuerle
    AAPS Open, 4 (1)
  • [26] Bioequivalence Evaluation of 2 Tablet Formulations of Entecavir in Healthy Chinese Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
    Jin, J.
    Liu, J.
    Chen, J.
    Zhao, L.
    Ma, Z.
    Chen, X.
    Huang, M.
    Zhong, G.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (03): : 113 - 116
  • [27] A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects
    Mona Darwish
    James M. Youakim
    Jim Harlick
    Daryl DeKarske
    Serge Stankovic
    Clinical Drug Investigation, 2022, 42 : 513 - 524
  • [28] A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects
    Darwish, Mona
    Youakim, James M.
    Harlick, Jim
    DeKarske, Daryl
    Stankovic, Serge
    CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 513 - 524
  • [29] A randomized, open-label, 2-period, crossover bioequivalence study of two oral formulations of 75 mg oseltamivir in healthy Thai volunteers
    Kongpatanakul, S.
    Chatsiricharoenkul, S.
    Panich, U.
    Sathirakul, K.
    Pongnarin, P.
    Sangvanich, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (12) : 654 - 662
  • [30] A randomized, open-label, two-period crossover study to evaluate the bioequivalence and food effect between two formulations of regorafenib in healthy adult participants
    Li, Yan
    Qi, Lu
    Yang, Caixia
    Zhao, Na
    Wang, Xinghe
    FRONTIERS IN PHARMACOLOGY, 2025, 16
12345